DeepMed Research

Catholic University of the Sacred Heart

Italy

Country: Italy

Ownership: Private

Established: 1921-01-01

Employees: -

Market Cap: -

Website: http://www.ucsc.it

Clinical Trials

Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study

Phase 2

Completed

Conditions: Effects of Chemotherapy
Peritoneal Cavity Cancer
Stage IV Ovarian Carcinoma

Interventions: Procedure: Laparoscopic interval debulking surgery

First Posted Date: 2014-12-24

Last Posted Date: 2016-04-13

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 30

Registration Number: NCT02324595

Locations: 🇮🇹
Catholic University of Sacred Heart Rome,, Rome,, Rome, Italy
🇮🇹
Policlinico Agostino Gemelli, Rome, Italy

2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial

Not Applicable

Completed

Conditions: Uterine Cervical Neoplasms
Laparoscopic Surgical Procedures

Interventions: Procedure: 3D Laparoscopy
Procedure: Standard Laparoscopy

First Posted Date: 2014-12-19

Last Posted Date: 2015-06-08

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 26

Registration Number: NCT02320578

Locations: 🇮🇹
Catholic University of the Sacred Heart, Rome, Italy

2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial

Not Applicable

Completed

Conditions: Endometrial Cancer

Interventions: Procedure: 3D Laparoscopy
Procedure: Standard Laparoscopy

First Posted Date: 2014-12-19

Last Posted Date: 2015-06-08

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 36

Registration Number: NCT02320565

Locations: 🇮🇹
Catholic University of the Sacred Heart, Rome, Italy

EUS GUIDED Transduodenal Biopsy Using the 19G Flex

Not Applicable

Completed

Conditions: Abdominal Neoplasms

Interventions: Device: Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA)

First Posted Date: 2014-12-04

Last Posted Date: 2022-06-27

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 246

Registration Number: NCT02307253

Locations: 🇺🇸
Indiana Univerisity Health Medical Center, Indianapolis, Indiana, United States
🇮🇹
AUSL Bologna Bellaria-Maggiore Hospital, Bologna, Italy
🇯🇵
Teikyo University Mizonokuchi Hospital, Departement of Gastroenterology, Kawasaki, Kanagawa, Japan

and more 3 locations

Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection

Phase 2

Completed

Conditions: Clostridium Difficile

Interventions: Other: Fecal Microbiota Transplantation
Drug: Standard Antibiotic Therapy
Drug: Vancomycin (before randomization)

First Posted Date: 2014-05-28

Last Posted Date: 2020-07-15

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 39

Registration Number: NCT02148601

Locations: 🇮🇹
Catholic University of Sacred Heart - "A. Gemelli" University Hospital, Rome, Italy

Post Operative Pain Control: Morphine vs Fentanyl

Not Applicable

Completed

Conditions: Post Operative Analgesia

Interventions: Drug: Morphine
Drug: Fentanyl

First Posted Date: 2014-05-26

Last Posted Date: 2014-05-26

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 60

Registration Number: NCT02146638

Locations: 🇮🇹
catholic University of the sacred Heart, Rome, Italy

Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial

Not Applicable

Completed

Conditions: Acute Respiratory Failure
Weaning Failure

Interventions: Device: Optiflow (Fisher & Paykel Healthcare)
Device: Venturi mask

First Posted Date: 2014-04-08

Last Posted Date: 2017-07-21

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 500

Registration Number: NCT02107183

Locations: 🇫🇷
Sainte-Marguerite University Hospital, Marseille, France
🇫🇷
Lapeyronie University Hospital, Montpellier, France
🇫🇷
Saint Eloi University Hospital, Montpellier, France

and more 11 locations

Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome

Phase 4

Completed

Conditions: Alcohol Withdrawal Syndrome
Alcohol Dependence

Interventions: Drug: Sodium Oxybate (SMO)
Drug: Oxazepam

First Posted Date: 2014-03-18

Last Posted Date: 2014-03-18

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 127

Registration Number: NCT02090504

Locations: 🇮🇹
"G. Fontana" Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Clinical Medicine, University of Bologna, Bologna, BO, Italy
🇮🇹
Catholic University of Rome, Rome, Rm, Italy
🇦🇹
University of Wien, Wien, AT, Austria

Lactobacillus Brevis CD2 Preventing Oral Mucositis

Phase 2

Conditions: Mucositis

Interventions: Drug: Lactobacillus brevis CD2

First Posted Date: 2014-03-13

Last Posted Date: 2014-03-13

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 10

Registration Number: NCT02085694

Locations: 🇮🇹
Policlinico Universitario "A. GEMELLI", Rome, Italy

Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS

Phase 4

Terminated

Conditions: Non ST Segment Elevation Acute Coronary Syndrome

Interventions: Drug: Clopidogrel
Drug: Ticagrelor

First Posted Date: 2014-02-26

Last Posted Date: 2016-07-26

Lead Sponsor: Catholic University of the Sacred Heart

Target Recruit Count: 55

Registration Number: NCT02071966

Locations: 🇮🇹
Policlinico "A.Gemelli", Rome, Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy